Medical

Breast Cancer: a Brighter Future For Patients As New Cutting-Edge Drugs Continue To Emerge!

With more and more new cutting-edge drugs emerging, the standard treatment paradigm for breast cancer is now rapidly changing, and the future is looking brighter for patients.

Medical

New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results

The FDA granted Fast Track designation to a new drug, IK-175, in combination with nabumab for the treatment of advanced uroepithelial carcinoma, after preliminary trial data showed encouraging and durable anti-tumor activity with a favorable safety profile.